🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/03/1991 | 16,52 | 16,66 | 16,44 | 16,60 | +0,60% | 1,32% | 2.097.048 |
| 22/03/1991 | 16,40 | 16,52 | 16,32 | 16,50 | +0,73% | 1,21% | 2.954.102 |
| 21/03/1991 | 16,56 | 16,64 | 16,30 | 16,38 | -0,72% | 2,04% | 4.040.040 |
| 20/03/1991 | 16,22 | 16,54 | 16,18 | 16,50 | +2,22% | 2,21% | 5.551.046 |
| 19/03/1991 | 16,66 | 16,66 | 15,82 | 16,14 | -4,13% | 5,01% | 8.057.443 |
| 18/03/1991 | 17,06 | 17,20 | 16,64 | 16,84 | -1,97% | 3,26% | 5.056.810 |
| 15/03/1991 | 17,24 | 17,26 | 17,02 | 17,18 | +0,12% | 1,38% | 8.589.408 |
| 14/03/1991 | 16,98 | 17,33 | 16,94 | 17,16 | +1,77% | 2,34% | 6.099.989 |
| 13/03/1991 | 16,78 | 16,96 | 16,62 | 16,86 | +0,47% | 2,01% | 2.558.587 |
| 12/03/1991 | 16,98 | 17,12 | 16,74 | 16,78 | -1,17% | 2,22% | 4.825.411 |
| 11/03/1991 | 16,82 | 17,10 | 16,80 | 16,98 | +1,07% | 1,77% | 3.186.758 |
| 08/03/1991 | 16,60 | 17,10 | 16,56 | 16,80 | +1,32% | 3,23% | 4.594.642 |
| 07/03/1991 | 16,32 | 16,68 | 16,32 | 16,58 | +0,85% | 2,19% | 3.175.440 |
| 06/03/1991 | 16,60 | 16,62 | 16,40 | 16,44 | -0,60% | 1,32% | 4.236.226 |
| 05/03/1991 | 16,32 | 16,66 | 16,32 | 16,54 | +0,97% | 2,07% | 3.656.472 |
| 04/03/1991 | 16,24 | 16,58 | 16,18 | 16,38 | +0,73% | 2,45% | 4.038.782 |
| 01/03/1991 | 15,98 | 16,30 | 15,90 | 16,26 | +0,12% | 2,49% | 3.992.251 |
| 28/02/1991 | 16,44 | 16,48 | 16,24 | 16,24 | -0,97% | 1,45% | 2.751.629 |
| 27/02/1991 | 16,26 | 16,52 | 16,20 | 16,40 | +1,35% | 1,96% | 3.430.104 |
| 26/02/1991 | 16,26 | 16,32 | 16,06 | 16,18 | -1,45% | 1,59% | 5.576.827 |
| 25/02/1991 | 16,44 | 16,62 | 16,24 | 16,42 | +1,47% | 2,30% | 5.389.445 |
| 22/02/1991 | 15,98 | 16,54 | 15,98 | 16,18 | +0,74% | 3,48% | 5.607.010 |
| 21/02/1991 | 15,98 | 16,10 | 15,86 | 16,06 | +0,25% | 1,49% | 3.997.282 |
| 20/02/1991 | 16,06 | 16,14 | 16,00 | 16,02 | -1,59% | 0,87% | 3.911.136 |
| 19/02/1991 | 16,14 | 16,28 | 16,10 | 16,28 | +0,37% | 1,11% | 6.820.594 |
| 15/02/1991 | 15,66 | 16,22 | 15,59 | 16,22 | +4,48% | 4,06% | 11.013.432 |
| 14/02/1991 | 15,70 | 15,84 | 15,43 | 15,53 | -1,01% | 2,66% | 5.911.978 |
| 13/02/1991 | 15,59 | 15,74 | 15,53 | 15,68 | +0,13% | 1,40% | 4.776.365 |
| 12/02/1991 | 15,78 | 16,02 | 15,64 | 15,66 | -1,87% | 2,39% | 6.553.982 |
| 11/02/1991 | 15,57 | 16,00 | 15,53 | 15,96 | +2,95% | 3,07% | 6.359.054 |